Herbrecht (voriconazole)
2002
Voriconazole versus Amphotericin B for Invasive Aspergillosis
In 277 patients with definite or probable invasive aspergillosis, voriconazole improved successful response and 12-week survival compared with amphotericin B deoxycholate.
Result
- Absolute difference
- 21.2 points
The absolute difference is derived from the event rates.
Also reported: 12-week survival 70.8 % vs 57.9 %.
- Subtopic
- Invasive aspergillosis
- Design
- Open-label RCT
- Relevance
- Important: one of several pillars.
- Source
- Herbrecht R, et al. N Engl J Med. 2002;347(6):408-415.doi 10.1056/NEJMoa020191
Discussion & critique
Established voriconazole as first-line therapy for invasive aspergillosis. Isavuconazole later proved a tolerability-equivalent alternative.